Merck & Co., Inc.
MX ˙ BMV ˙ US58933Y1055
SecurityMX:MRK / Merck & Co., Inc.
InstitutionNew Hampshire Trust
Latest Disclosed Ownership55,630 shares
Latest Disclosed Value $ 6,691,732
New Hampshire Trust reports 0.27% decrease in ownership of MRK / Merck & Co., Inc.

On April 20, 2026 - New Hampshire Trust filed a 13F-HR form disclosing ownership of 55,630 shares of Merck & Co., Inc. (MX:MRK) valued at $6,691,732 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 55,781 shares of Merck & Co., Inc.. This represents a change in shares of -0.27% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F Merck & Co Inc Equities 58933Y105 55,630 -151 -0.27 6,692 13.97 0.8182
2026-01-29 2025-12-31 13F Merck & Co Inc Equities 58933Y105 55,781 -3,434 -5.80 5,872 18.15 1.1426
2025-10-16 2025-09-30 13F Merck & Co Inc Equities 58933Y105 59,215 5,471 10.18 4,970 16.81 0.9596
2025-07-31 2025-06-30 13F Merck & Co Inc Equities 58933Y105 53,744 941 1.78 4,254 -10.23 0.8888
2025-04-08 2025-03-31 13F Merck & Co Inc Equities 58933Y105 52,803 3,427 6.94 4,740 -3.50 1.0841
2025-01-16 2024-12-31 13F Merck & Co Inc Equities 58933Y105 49,376 834 1.72 4,912 -10.90 1.0349
2024-10-17 2024-09-30 13F Merck & Co Inc Equities 58933Y105 48,542 -86 -0.18 5,512 -8.44 1.1809
2024-07-15 2024-06-30 13F Merck & Co Inc Equities 58933Y105 48,628 153 0.32 6,020 -5.88 1.3734
2024-04-09 2024-03-31 13F Merck & Co Inc Equities 58933Y105 48,475 -950 -1.92 6,396 18.71 1.4954
2024-01-12 2023-12-31 13F Merck & Co Inc Equities 58933Y105 49,425 -73 -0.15 5,388 5.75 1.2955
2023-10-17 2023-09-30 13F Merck & Co Inc Equities 58933Y105 49,498 -322 -0.65 5,096 -11.36 1.3848
2023-07-11 2023-06-30 13F Merck & Co Inc Equities 58933Y105 49,820 -1,156 -2.27 5,749 5.99 1.4938
2023-04-18 2023-03-31 13F Merck & Co Inc Com 58933Y105 50,976 -5,461 -9.68 5,423 -13.38 1.4552
2023-02-10 2022-12-31 13F Merck & Co Inc Com 58933Y105 56,437 56,437 6,262 1.6578
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.